✦ LIBER ✦

HLA antigens in Italian multiple sclerosis patients

✍ Scribed by L. La Mantia; M. T. Illeni; C. Milanese; A. Salmaggi; M. Eoli; G. Pellegris; A. Nespolo

Publisher: Springer Milan
Year: 1991
Tongue: English
Weight: 432 KB
Volume: 12
Category: Article
ISSN: 1590-1874
DOI: 10.1007/bf02337618

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multiple sclerosis, sleep latencies and

Multiple sclerosis, sleep latencies and HLA antigens

✍ L. Rumbach; M. M. Tongio; J. M. Warter; M. Collard; D. Kurtz 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 212 KB

HLA-antigens and the prognosis of multip

HLA-antigens and the prognosis of multiple sclerosis

✍ Sigrid Poser; G. Ritter; H. J. Bauer; H. Grosse-Wilde; E. K. Kuwert; N. E. Raun 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 143 KB

The histocompatibility pattern of 160 patients with multiple sclerosis (MS) living in the epidemiological area of Southern Lower Saxony was determined and compared to a control population. The only significant difference was the more frequent occurrence of DW2 in the patient group (44% vs. 21%). Tak

HLA antigens-linked genetic control in m

HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection

✍ G. Lamoureux; P. Duquette; Y. Lapierre; B. Cosgrove; G. Bourret; L. Labrie 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 739 KB

Patients with multiple sclerosis (MS) from the two Montreal MS clinics, were divided into two groups: one group of 61 patients (MS type I) who had no clinical history of susceptibility to recurrent respiratory tract infections and a second group of 58 patients (MS type II) who had persistent suscept

HLA antigens and progression of multiple

HLA antigens and progression of multiple sclerosis. Part II

✍ L. Dejaegher; M. Bruyere; P. Ketelaer; H. Carton 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 375 KB

The HLA-A, -B, -C and -D were determined in 200 multiple sclerosis (MS) patients, 64 of whom underwent a CSF examination. Their frequencies were correlated with the rate of disease progression and with factors thought to influence disease progression, including onset age, type of clinical course and

HLA-SD antigens in progressive systemic

HLA-SD antigens in progressive systemic sclerosis

✍ Mario Giordano; Daniela Magrí; Gabriele Valentini; Giuseppe Tirri; Raffaello Bia 📂 Article 📅 1979 🏛 Springer-Verlag 🌐 English ⚖ 58 KB

HLA and prognosis in multiple sclerosis

✍ Björn Runmarker; Tommy Martinsson; Jan Wahlström; Oluf Andersen 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 581 KB